Rheumatology Update 2023

First presented at the FOMA 2023 Virtual Convention. FOMA is proud to offer this on-demand CME program as Susan L. Zito, DO, MPH, FACOI, FACR shares her knowledge on the latest updates regarding medications and rheumatology.

Following completion of this program, attendees shall be ale to:

Review Lupus and Advances in Therapies • Examine 2022 New FDA indications for Previously Approved Rheumatology Medications since Rheumatology was not among the 37 Novel Drugs. • Consider Autoimmune Patients and Coronavirus • Discuss Diagnosis and Treatment of Spondyloarthritis and non-radiographic Spondyloarthritis • Understand Biosimilars and Implications for Patients • Review Updated Guidelines from EULAR, ACR and GRAPPA

Dr. Zito has no actual or potential conflict of interest in relation to this program or presentation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Florida Osteopathic Medical Association (FOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

GRIEVANCE POLICY: The FOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to FOMA Executive Director Steve Winn, by calling the FOMA Office at 850-878-7364 or by mail to FOMA, 2544 Blairstone Pines Drive, Tallahassee, FL  32301, or by email to admin@foma.org